Results 1 to 10 of about 411,697 (349)

Global epidemiology of systemic lupus erythematosus

Nature Reviews Rheumatology, 2021
Megan R W Barber, Cristina Drenkard, Titilola Falasinnu   +2 more
exaly   +2 more sources

Autoimmunity and organ damage in systemic lupus erythematosus

Nature Immunology, 2020
George C Tsokos
exaly   +2 more sources

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

Annals of the Rheumatic Diseases, 2023
Objectives To update the EULAR recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. Methods An international Task Force formed the questions for the systematic literature reviews (January 2018–December ...
A. Fanouriakis, M. Kostopoulou, Jeanette Andersen, M. Aringer, Laurent Arnaud, Sang‐Cheol Bae, John Boletis, I. Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, R. Furie, D. Gladman, F. Houssiau, L. Inês, D. Jayne, M. Kouloumas, László Kovács, C. Mok, Eric F. Morand, Gabriella Moroni, Marta Mosca, J. Mucke, C. Mukhtyar, György Nagy, S. Navarra, Ioannis Parodis, J. Pego-Reigosa, M. Petri, Bernardo A Pons-Estel, M. Schneider, J. Smolen, E. Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y. Teng, A. Tincani, E. Vital, RF van Vollenhoven, Chris Wincup, G. Bertsias, Dimitrios T Boumpas   +41 more
semanticscholar   +1 more source

Lupus erythematosus

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2023
SummaryCutaneous lupus erythematosus can manifest with or without systemic involvement resulting in a broad clinical spectrum. Disease pathogenesis is often characterized by a loss of tolerance to endogenous antigens and a chronic relapsing activation of the innate and adaptive immune system.
Claudia, Günther, Jörg, Wenzel
openaire   +2 more sources

Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature

Brain Sciences, 2021
(1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies.
Alba Jerez-Lienas, Alexis Mathian, Jenifer Aboab, Isabelle Crassard, Miguel Hie, Fleur Cohen-Aubart, Julien Haroche, Denis Wahl, Ricard Cervera, Zahir Amoura   +9 more
doaj   +1 more source

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

Arthritis & Rheumatology, 2022
To assess the efficacy and safety of deucravacitinib, an oral, selective, allosteric inhibitor of TYK2, in a phase II trial in adult patients with active systemic lupus erythematosus (SLE).
Eric F Morand, M. Pike, J. Merrill, R. V. van Vollenhoven, V. Werth, C. Hobar, N. Delev, V. Shah, B. Sharkey, T. Wegman, I. Catlett, Subhashish Banerjee, S. Singhal   +12 more
semanticscholar   +1 more source

Different distribution patterns of plasmacytoid dendritic cells in discoid lupus erythematosus and lichen planopilaris demonstrated by CD123 immunostaining, [PDF]

Anais Brasileiros de Dermatologia, 2020
Background: Clinical and histological features may overlap between lichen planopilaris-associated and discoid lupus erythematosus-associated scarring alopecia.
Azadeh Rakhshan, Parviz Toossi, Maliheh Amani, Sahar Dadkhahfar, Arash Bagheri Hamidi   +4 more
doaj   +1 more source

Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta‐Analysis of the Centers for Disease Control and Prevention National Lupus Registries

Arthritis & Rheumatology, 2021
Epidemiologic data on systemic lupus erythematosus (SLE) are limited, particularly for racial/ethnic subpopulations in the US. This meta‐analysis leveraged data from the Centers for Disease Control and Prevention (CDC) National Lupus Registry network of ...
P. Izmirly, Hilary B. Parton, Lu Wang, W. McCune, S. S. Lim, Cristina Drenkard, E. Ferucci, M. Dall'Era, Caroline Gordon, Charles G. Helmick, E. Somers   +10 more
semanticscholar   +1 more source

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Arthritis & Rheumatology, 2019
To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
M. Aringer, K. Costenbader, D. Daikh, R. Brinks, M. Mosca, R. Ramsey‐Goldman, J. Smolen, D. Wofsy, D. Boumpas, D. Kamen, D. Jayne, R. Cervera, N. Costedoat-Chalumeau, B. Diamond, D. Gladman, B. Hahn, F. Hiepe, S. Jacobsen, D. Khanna, K. Lerstrøm, E. Massarotti, Joseph Mccune, G. Ruiz‐Irastorza, J. Sánchez-Guerrero, Matthias Schneider, M. Urowitz, G. Bertsias, B. Hoyer, N. Leuchten, C. Tani, S. Tedeschi, Z. Touma, G. Schmajuk, B. Anić, F. Assan, T. Chan, A. Clarke, M. Crow, L. Czirják, A. Doria, W. Graninger, Bernadett Halda-Kiss, S. Hasni, P. Izmirly, M. Jung, G. Kumánovics, X. Mariette, I. Padjen, J. Pego-Reigosa, J. Romero-Díaz, Íñigo Rúa-Figueroa Fernández, R. Seror, G. Stummvoll, Yoshiya Tanaka, M. Tektonidou, C. Vasconcelos, E. Vital, D. Wallace, Ş. Yavuz, Pier Luigi Meroni, M. Fritzler, R. Naden, T. Dörner, S. Johnson   +63 more
semanticscholar   +2 more sources

Lichen planus-lupus erythematosus overlap syndrome [PDF]

Vestnik Dermatologii i Venerologii, 2022
The combination of lichen planus and lupus erythematosus is a rarity: no more than fifty cases of overlap syndrome have been described in the world. The clinical picture of overlap syndrome is variable: patients have discoid foci of lupus erythematosus ...
Marina Yu. Nikolaeva, Konstantin N. Monakhov, Evgeny V. Sokolovskiy   +2 more
doaj   +1 more source